Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Cardiff Oncology, Inc. (CRDF) had Return on Equity of -15.90% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.24M |
|
$-7.22M |
|
-- |
|
$0.24M |
|
$8.07M |
|
$-7.83M |
|
$0.61M |
|
$-7.22M |
|
$-7.22M |
|
$-7.22M |
|
$-7.22M |
|
$-7.22M |
|
$-7.22M |
|
$-7.83M |
|
$-7.90M |
|
66.84M |
|
66.84M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$60.13M |
|
$0.58M |
|
$1.76M |
|
$61.88M |
|
$16.39M |
|
-- |
|
$0.10M |
|
$16.50M |
|
$45.39M |
|
$45.39M |
|
$45.39M |
|
68.31M |
|
| Cash Flow Statement Financials | |
$-37.92M |
|
$1.34M |
|
$2.58M |
|
$51.47M |
|
$17.47M |
|
$-34.00M |
|
$5.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3220.99% |
|
-3220.99% |
|
-- |
|
-2969.55% |
|
-2972.43% |
|
$-37.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.34 |
|
67.41 |
|
|
Return on Equity |
-15.90% |
-15.90% |
|
-11.66% |
|
-15.90% |
|
$0.66 |
|
$-0.57 |
|
$-0.57 |
|